CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 118 enrolled
Drug / intervention
solifenacindrug
Likely dose
solifenacin 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01470001
NCT01470001N/ACompleted
CompareCT.gov

The Effect of Solifenacin on Post Void Dribbling in Women: A Randomized Controlled Multicenter Trial

University of Wisconsin, Madison·interventional·Posted Nov 10, 2011·Updated Aug 23, 2017

In Brief

A clinical study evaluating solifenacin for Post-micturition Incontinence and Incontinence. Completed, enrolled 118 participants across 1 site.

Detailed Summary

This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-micturition Incontinence, Incontinence
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 10, 2011
Enrollment StartNov 1, 2011
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.6 years ago

Interventions

solifenacindrug

patient will receive solifenacin 5mg daily or placebo daily